Industry, FDA Discuss Making CIR Program ‘More Robust’

As the cosmetics industry works to instill confidence in product safety and the mechanisms in place to vet ingredients, the Personal Care Products Council recently met with FDA to talk about refining the Cosmetic Ingredient Review program. The trade group wants to establish CIR panel findings as a first-line resource for FDA, particularly if legislation advances that would direct the agency to evaluate cosmetic ingredients for safety.

Should FDA take an active role in evaluating the safety of cosmetic ingredients, the Personal Care Products Council aims to ensure that Cosmetic Ingredient Review Expert Panel findings are front and center in the agency’s considerations.

Under a bill anticipated to be introduced by Sen. Dianne Feinstein, D-Calif., FDA would be expected to review five cosmetic...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

US FDA’s Tough Talk On Talc: Regulating In An Echo Chamber

 

An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.

US Tariff Overhang Weighs on Chinese API Exports

 

Chinese API exports to US fell 24% year-on-year to $255m in May, when US and China called a truce in a previously escalating trade war.

AstaReal Launches Membralife Supplement Following CEO Change

 
• By 

Designed to help moisturize the body’s mucous membranes, the Membralife supplement is now available in Sweden. The launch comes with AstaReal now under new management following the appointment of Daniel Flodqvist as CEO.